Company page

Walvax Biotechnology Co., Ltd. Class A

Walvax Biotechnology Co., Ltd. Class A is a publicly traded company in China, with a market capitalization of approximately 2.94 billion USD. The company is focused on biopharmaceuticals, specializing in the development and production of vaccines and other biological products. As a key player in the biotechnology sector, Walvax aims to contribute to public health through innovative solutions.